Geneoscopy Employee Directory
Biotechnology ResearchMissouri, United States51-200 Employees
Geneoscopy, Inc. is a biotechnology research company based at 2220 Welsch Industrial Court, St. Louis, Missouri 63146, United States, with 51-200 employees. It develops diagnostic tests for gastrointestinal health using a proprietary stool-derived eukaryotic RNA (seRNA) biomarker platform. Its ColoSense test is FDA-approved for screening colorectal cancer and advanced adenomas in average-risk individuals over 45. The company collaborates with universities and biopharmaceutical companies to develop diagnostics for treatment selection and therapy monitoring across GI diseases. Recent developments include a January 2025 Series C financing and an integration of ColoSense with Bio-Rad Laboratories' QXDx ddPCR platform.